Combined MSC and GLP-1 Therapy Modulates Collagen Remodeling and Apoptosis following Myocardial Infarction
Background. Mesenchymal stem cells (MSCs) and glucagon-like peptide-1 (GLP-1) are being tested as treatment strategies for myocardial infarction (MI); however, their mechanisms in the heart are not fully understood. Methods. We examined the effects of MSCs, either native, or engineered to secrete a...
Saved in:
Main Authors: | Elizabeth J. Wright, Nigel W. Hodson, Michael J. Sherratt, Moustapha Kassem, Andrew L. Lewis, Christine Wallrapp, Nadim Malik, Cathy M. Holt |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2016/7357096 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recent Developed Strategies for Enhancing Chondrogenic Differentiation of MSC: Impact on MSC-Based Therapy for Cartilage Regeneration
by: Kangkang Zha, et al.
Published: (2021-01-01) -
The GLP-1R agonist semaglutide reshapes pancreatic cancer associated fibroblasts reducing collagen proline hydroxylation and favoring T lymphocyte infiltration
by: Chiara Cencioni, et al.
Published: (2025-01-01) -
Heterogeneity of MSC: Origin, Molecular Identities, and Functionality
by: Xueqing Liu, et al.
Published: (2019-01-01) -
Sex Hormones, Apoptosis and the Fas/Fas Ligand System in Normal Endometrial Tissue Remodeling
by: Gil Mor, et al.
Published: (2001-01-01) -
Postmyocardial Infarct Remodeling and Heart Failure: Potential Contributions from Pro- and Antiaging Factors
by: Halliday A. Idikio
Published: (2011-01-01)